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Introduction
KSHV is the etiologic agent of Kaposi’s sarcoma (KS) (Chang 
et al., 1994; Chang and Moore, 1996). Like other herpesviruses, 
KSHV establishes a latent infection in infected cells but lytic rep-
lication can occur spontaneously or upon activation by various 
stimuli (Jenner et al., 2001; Sarid et al., 1998). Induction of KSHV 
lytic gene expression occurs via the expression of the replication 
and transcription activator RTA (Gradoville et al., 2000; Lukac et 
al., 1998; Sun et al., 1998). RTA activates the transcription of var-
ious viral genes, and one of the highly responsive genes to RTA-
mediated transactivation is ORF57 (West and Wood, 2003). The 
transactivation activity of RTA can be modulated by many cel-
lular and viral factors through different mechanisms (West and 
Wood, 2003). One of these cellular factors is a KRAB-containing 
zinc finger protein ZnF426 which we have identified previously; it 
interacts with the KSHV RTA, and was named KSHV RTA bind-
ing protein (K-RBP) (Wang et al., 2001).
KRAB (Kruppel-associated box)-containing zinc finger pro-
teins are the largest family of zinc finger regulatory proteins en-
coded in the human genome with about 300 members. They play 
important roles in various cellular processes, such as cell differ-
entiation, apoptosis and neoplastic transformation (Urrutia, 2003). 
The KRAB-containing zinc finger proteins are characterized by the 
presence of 1–2 KRAB domains at N-terminus followed by multi-
ple C2H2 zinc finger motifs. Many of the KRAB domains repress 
transcription when tethered to DNA. The KRAB domains also in-
teract with proteins, such as TIF1β, and their interactions are im-
portant for their repression function (Moosmann et al., 1996). The 
tandem C2H2 zinc fingers in KRAB-containing zinc finger proteins 
were proposed to recognize specific DNA elements and bind to 
DNA. However, not all zinc fingers bind DNA and not all zinc fin-
gers contribute equally to the DNA-binding specificity in proteins 
containing multiple zinc finger motifs (Peng et al., 2002). Further-
more, there is at least one zinc finger protein that was found not to 
bind to DNA (Kwan et al., 2003).
Similar to other KRAB-containing zinc finger proteins, K-RBP 
contains a Kruppel-associated box (KRAB) at the N-terminus and 
multiple zinc finger motifs at the C-terminus; and it is expressed 
in a number of different cell lines tested (Wang et al., 2001). The K-
RBP protein represses RTA-mediated transactivation and knock-
down of K-RBP expression enhances RTA-mediated transactiva-
tion of gene driven by the ORF57 promoter. More interestingly, 
knockdown of K-RBP expression in KSHV latently infected cells 
also increases KSHV-RTA-mediated lytic gene expression, sug-
gesting that K-RBP plays a role in repressing RTA-mediated 
KSHV lytic gene expression in latently infected cells (Yang and 
Wood, 2007). Therefore, it is of interest to characterize the mo-
lecular properties of K-RBP to study the mechanism of its func-
tion on viral promoters. The KRAB domain of K-RBP is a repres-
sion domain but the role of its zinc finger motifs has not yet been 
defined (Yang and Wood, 2007). Whether the zinc finger motifs 
of K-RBP bind to DNA, especially the viral promoter, and play a 
role in repressing KSHV promoter is of interest and needs to be 
investigated.
In this report, we demonstrate that K-RBP binds DNA through 
its zinc finger motifs and the binding elements are GC-rich. In ad-
dition, we found that the DNA-binding activity of K-RBP signif-
icantly contributes to the repression of KSHV ORF57 gene pro-
moter in the absence and presence of RTA. It is possible that 
K-RBP regulates other viral gene expression and viral replication 
using a similar mechanism. The characterization of K-RBP DNA-
binding activity and identification of K-RBP binding sequences 
will provide important molecular insights towards understanding 
the functions of K-RBP and its role in regulating KSHV gene ex-
pression and replication at the molecular level.
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Abstract
K-RBP is a KRAB-containing zinc finger protein with multiple zinc finger motifs and represses Kaposi’s sarcoma-associated herpesvirus 
(KSHV) transactivator RTA-mediated transactivation of several viral lytic gene promoters, including the ORF57 promoter. Whether K-
RBP binds DNA through its zinc fingers and the role of zinc finger domain in repressing gene expression are unclear. Here we report that 
K-RBP binds DNA through its zinc finger domain and the target DNA sequences contain high GC content. Furthermore, K-RBP binds to 
KSHV ORF57 promoter, which contains a GC-rich motif. K-RBP suppresses the basal ORF57 promoter activity as well as RTA-mediated 
activation. The zinc finger domain of K-RBP is sufficient for the suppression of ORF57 promoter activation mediated by the viral transac-
tivator RTA. Finally, we show that K-RBP inhibits RTA binding to ORF57 promoter. These findings suggest that the DNA-binding activ-
ity of K-RBP plays an important role in repressing viral promoter activity.
Keywords: KSHV/HHV-8, zinc finger, DNA binding, transcription repression
221
222  Yan g, Wen, Mi n h as, & Wo o d i n Virology  391 (2009)
Results
Expression and purification of recombinant K-RBP protein
K-RBP contains 12 zinc finger motifs, with 11 of them being 
classic C2H2 motifs and the other one being a non-typical C2H2 
motif (Figure 1A). In addition, 6 of the 11 linkers between the 
zinc fingers of K-RBP are composed of the sequence TG(E)EKPY 
which is a common canonical sequence in tandem DNA-binding 
C2H2 zinc finger proteins (Wolfe et al., 2000). Even though zinc 
finger motifs are well-known DNA-binding motifs, not all zinc 
finger proteins bind DNA (Kwan et al., 2003). To test whether K-
RBP binds to DNA, recombinant His-tagged K-RBP was over-ex-
pressed to a high level in E. coli and could be detected in the insol-
uble fraction of the bacterial lysate (Figure 1B). The protein was 
purified and then refolded by dialyzing against refolding buffer. 
Coomassie blue staining of the SDS-PAGE and Western blot anal-
ysis showed that the refolded protein was pure (Figure 1C). The 
purified and refolded K-RBP protein was subsequently used for 
DNA-binding analysis.
K-RBP binds DNA via its zinc finger domain
To investigate whether K-RBP binds DNA, we conducted an in 
vitro DNA cellulose assay. K-RBP protein was examined for its as-
sociation with cellulose alone or cellulose conjugated to dsDNA. 
Consistent with it being a potential DNA-binding protein, K-RBP 
bound tightly to dsDNA cellulose but not to cellulose alone (Fig-
ure 2A). In addition, the DNA-binding activity of K-RBP was af-
fected by the addition of Zn2+. An increase in ZnSO4 concentration 
Figure 1. (A) Schematic representation of K-RBP protein showing the 
KRAB domain and 12 zinc finger motifs. Amino acid alignment of the 
zinc finger motifs in K-RBP showing the amino acids involved in Zn2+ 
binding (in bold). The − 1, + 3 and + 6 indicate the amino acids in the 
α-helical region of a zinc finger motif that determine its DNA-binding 
specificity. (B) Coomassie blue staining of cell lysates from E. coli ex-
pressing K-RBP protein. Lane 1: protein marker; Lane 2: lysate from 
E. coli cells containing K-RBP expression plasmid without IPTG induc-
tion; Lane 3: soluble fraction of Lysate from E. coli cells containing K-
RBP expression plasmid with IPTG induction; Lane 4: insoluble frac-
tion of the lysate from E. coli cells harboring K-RBP expression plasmid 
with IPTG induction. Arrow indicates K-RBP protein. (C) Coomassie 
blue staining and Western blot analysis of His-tagged K-RBP protein 
after purification, urea-solubilization and refolding. Lane 1: Coomassie 
blue staining of K-RBP protein after purification; Lane 2: Coomassie 
blue staining of K-RBP protein after refolding; Lane 3: Western blot 
analysis of protein using anti-His antibody after refolding. Arrow indi-
cates K-RBP protein. 
Figure 2. DNA-binding activity of K-RBP protein. (A) The bacterially ex-
pressed K-RBP was refolded and incubated with cellulose without DNA-
conjugation or dsDNA cellulose. The bound (B) and non-bound (NB) frac-
tions were separated by centrifugation. The bound protein was washed 
and eluted by increasing concentrations of NaCl in the binding buffer. The 
K-RBP protein in different fractions was separated by SDS-PAGE and an-
alyzed by Western blot using anti-K-RBP antibody. (B) K-RBP was incu-
bated with dsDNA cellulose in the presence of ZnSO4 and EDTA. DNA 
cellulose bound protein was eluted with 1.25% SDS. (C) Zinc finger do-
main, but not KRAB domain of K-RBP binds DNA. The E. coli expressed 
His-tagged KRAB domain (1–98), zinc finger domain (141–554), full-length 
K-RBP and E. coli lysate were resolved on SDS-PAGE, transferred to PVDF 
membrane and analyzed by Western blot using anti-His antibody (left 
panel). The second membrane with the same samples was incubated in K-
RBP refolding buffer overnight at 4 °C and hybridized to the random ds-
DNA probe labeled with [α-32P] dATP (right panel). 
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resulted in more K-RBP being bound to DNA, and the addition 
of metal-chelating reagent EDTA inhibited K-RBP binding (Figure 
2B). This suggests that Zn2+ is required for optimal DNA binding 
by K-RBP. Similar effect was also observed with another KRAB-
containing zinc finger protein (Jheon et al., 2001).
To examine whether K-RBP binds DNA through its zinc fin-
ger domain, full-length His-tagged K-RBP and two truncated K-
RBP clones, KRAB domain K-RBP1-98 and zinc finger domain 
K-RBP141-554, were constructed, and the resulting proteins ex-
pressed in E. coli were used in DNA filter binding assay. Mem-
brane-immobilized full-length K-RBP and zinc finger domain (K-
RBP141-554), but not KRAB domain (K-RBP1-98), were found to 
bind [α-32P] dATP labeled DNA (Figure 2C). These results indi-
cate that the zinc finger domain of K-RBP is responsible for the 
DNA-binding activity of K-RBP.
Identification of K-RBP binding sequences
To investigate whether K-RBP binds specific DNA sequences, 
we incubated the His-tagged K-RBP fusion protein with a pool of 
double-stranded 63-mers containing 27 nucleotides of random se-
quence, N27. The K-RBP bound oligonucleotides were recovered 
by Ni-NTA, amplified by PCR, and reselected as described in “Ma-
terials and Methods” and shown in Figure 3A. A total of 33 clones 
were analyzed and 70% of them (23 clones) contain (T/G)CGG or 
its complementary sequence CCG(A/C) in the randomly synthe-
sized region (data not shown). This result suggests that (T/G)CGG 
sequence could be a core motif for K-RBP binding.
To better define the K-RBP binding sequences, we performed a 
second set of selection with oligomers containing the central CGG 
core identified during the first selection flanked by 14 and 15 nu-
cleotides of random sequences at each end (N14-CGG-N15). After 
8 rounds of selection, the selected oligonucleotides were cloned 
and sequenced. A total of 100 clones were sequenced, of which 82 
good quality sequences were analyzed and the frequencies of dif-
ferent nucleotides appearing at each position were calculated. The 
analysis revealed a GC-rich feature, with a GC-rich element in the 
consensus sequence: G(G/T)GGG(G/T)G(G/T)NNGCGGG(G/
T)GG (Figure 3B). Notably, several sequences featured multiple 
times among the selected 82 clones, and all of them were rich in 
GC content. These results suggest that K-RBP preferably binds to 
sequences with high GC content.
To confirm the binding of K-RBP with the selected sequences, 
we performed EMSA using one of the selected DNA target clone 
#14 as a probe. This sequence was present in 7 out of 82 analyzed 
sequences (Figure 3C). The result showed that the K-RBP protein 
bound the probe specifically, and increasing amounts of protein 
resulted in stronger binding (Figure 3C, lanes 2 and 3). The bind-
ing was competed efficiently by the unlabeled clone #14 probe 
but not by Oct-1 binding element probe which is not GC-rich (Fig-
ure 3C, lanes 4 and 5). In addition, when the K-RBP protein was 
depleted by Ni-NTA beads prior to binding, the intensity of the 
protein–DNA complex decreased. However, the addition of GST 
beads had no effect (Figure 3C, lanes 6 to 8). We also used anti-
His antibody to test for a supershift of the K-RBP/DNA complex. 
However, the addition of this antibody did not generate a super-
shifted band but the intensity of the K-RBP/DNA complex band 
decreased significantly. In contrast, the anti-Flag antibody had lit-
tle effect (Figure 3C, lanes 9 to 12). These results suggest that bind-
ing of K-RBP to this probe is specific.
K-RBP binds KSHV ORF57 promoter and suppresses its activity
K-RBP has been shown to suppress KSHV ORF57 and K8 pro-
moter activities activated by RTA (Yang and Wood, 2007). We 
found a GC-rich element beside RTA response elements in ORF57 
promoter. The ORF57 gene is an important early protein required 
for KSHV lytic replication (Duan et al., 2001; Lukac et al., 2001; 
Wang et al., 2005) and we tested whether K-RBP actually binds 
this promoter and whether the binding can lead to the suppres-
sion of the promoter activity. Figure 4A shows the schematic rep-
resentation of the ORF57 promoter in which we have identified at 
least two RTA binding elements (RRE1 and RRE2) (Wang et al., 
2005). The GC-rich element is located between RRE1 and RRE2. 
We then performed EMSA using 57R, 57RRE2, the entire promoter 
element 57P and clone #14 as probes to determine their interaction 
with K-RBP. K-RBP bound to the 57P and 57R probes, but poorly 
to 57RRE2. Binding of K-RBP to 57P was stronger than that of 57R 
(Figure 4B). These results suggest that even though the AT-rich 
57RRE2 is not a preferable binding target of K-RBP, it enhances 
the binding of K-RBP to 57R since stronger binding of K-RBP to 
57P was observed relative to 57R (Figure 4B). The binding of K-
RBP to 57R was specific because increasing protein/DNA com-
plex was observed with an increasing amount of protein added 
(Figure 4C, lanes 7 and 8). The addition of the various unlabeled 
competitors which included clone #14, 57R and 57P significantly 
decreased binding of K-RBP to 57R, but the addition of 57RRE2 
and the unrelated Oct-1 binding element had little or no inhibitory 
effect (Figure 4C, lanes 3, 4, 5, 9 and 10). It is interesting to note 
that although clone #14 cold probe can only partially compete 
with K-RBP for binding to 57R at an 80-fold excess, it completely 
inhibited K-RBP binding at a 200-fold excess (data not shown). 
This suggests that the binding between K-RBP and ORF57 pro-
moter is strong. Depletion of K-RBP protein by Ni-NTA beads but 
not GST beads reduced the intensity of the protein–DNA complex 
(Figure 4C, lanes 11 to 13). Also, anti-His antibody diminished K-
RBP binding to 57R, but anti-Flag antibody had no effect (Figure 
4C, lanes 14 to 15). These results demonstrate that K-RBP can spe-
cifically bind to ORF57 promoter.
Since K-RBP is a transcriptional repressor, the binding of K-
RBP to the ORF57 promoter may play a role in suppression of the 
promoter activity. Therefore we performed luciferase reporter as-
say in transfected 293T cells to investigate this possibility. The 
schematic representations of the luciferase reporter constructs of 
ORF57 promoter and the mutants used in the study are shown in 
Figure 5A. Plasmid pGL3-basic was used for the construction of 
the luciferase reporters. The p57Pluc1 and p57-3RRE contain the 
intact ORF57 RREs; the p57-3RRE4 has deletion in RRE1 and does 
not contain the GC-rich element; p57-3RRE2 has a deletion in the 
GC-rich element of p57-3RRE. K-RBP had only a marginal sup-
pressive effect on pGL3-basic at high concentration (Figure 5B), 
but strongly suppressed p57Pluc1 and p57-3RRE with the intact 
GC-rich element (Figures 5C and D). As expected, K-RBP did not 
suppress p57-3RRE4 and p57-3RRE2, which lack the GC-rich el-
ement (Figures 5E and F). These results together suggest that K-
RBP binds the ORF57 promoter via the GC-rich element and func-
tionally suppresses the promoter activity.
The zinc finger domain of K-RBP alone can repress KSHV RTA-acti-
vated ORF57 gene promoter
We have shown that K-RBP can repress RTA-mediated ORF57 
gene promoter activation in 293T cells in an earlier study (Yang 
and Wood, 2007). Similar effect can be observed in another cell 
line, BJAB cells, and the expression of K-RBP readily suppressed 
RTA-activated ORF57 gene expression (Figure 6A). We next 
sought to determine whether the DNA-binding activity of K-RBP 
is required to mediate the repression. Several GAL4BD-tagged 
K-RBP deletion mutants were tested for their effect on RTA-acti-
vated ORF57 promoter. The use of GAL4BD tag would provide 
nuclear localization to the truncated proteins and the ORF57 pro-
moter construct does not contain GAL4 binding site. Plasmids 
pBDK-RBP42-98 and pBDK-RBP1-98 retain the N-terminal KRAB 
domain; pBDK-RBP99-554 and pBDK-RBP214-554 retain the full 
and partial zinc finger domains, respectively (Figure 6E). Interest-
ingly, as shown in Figures 6B and C, K-RBP99-554 repressed RTA-
activated ORF57 luciferase reporter activity to a similar level as 
full-length K-RBP, but K-RBP1-98 failed to cause any repression. 
On the contrary, the addition of deletion mutant K-RBP1-98 en-
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Figure 3. Selection of K-RBP binding sequences. 
(A) Schematic representation of the procedure 
used to identify K-RBP binding sequences. (B) 
Consensus (Con) sequences for K-RBP binding. 
Numbers indicate the frequencies of the spe-
cific nucleotide at each position (Pos). The most 
abundant nucleotides at each position were 
used to generate the consensus sequence shown 
in the bottom. The underlined CGG motif was 
pre-synthesized in the pool of the second round 
selection oligomers. (C) K-RBP binds clone #14 
probe in EMSA. The probe was labeled with [α-
32P]dATP. The clone #14 and Oct-1 probe were 
used as unlabeled competitors. Unlabeled com-
petitors were added at an 80–100-fold molar ex-
cess over the labeled probe. Various amounts of 
Ni-NTA agarose beads (5 and 15 μl) were used 
to remove the His-tagged K-RBP protein in 
EMSA. GST beads (15 ml) were used as a con-
trol. Mouse anti-His or Flag antibodies were 
added in the reaction prior to adding the probe 
as shown in lanes 11 and 12. The arrow indi-
cates the bound complex. One microliter K-RBP 
protein contains 5 ng purified K-RBP protein 
approximately. 
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hanced RTA-mediated transcriptional activation by about 2-fold 
(Figure 6C). The effect of deletion mutant K-RBP214-554 was simi-
lar to K-RBP99-554 which also repressed RTA-mediated transacti-
vation (Figure 6E). The effect of deletion mutant K-RBP42-98 was 
similar to K-RBP1-98. It enhanced RTA-mediated transactivation 
by about 2-fold (Figure 6E and data not shown). The repression 
of RTA-mediated transactivation by the K-RBP zinc finger domain 
was also observed in 293T cells (Data not shown). Since K-RBP99-
554 retained its repressor activity on RTA-mediated activation of 
ORF57 promoter but K-RBP1-98 did not, we examined the expres-
sion levels of the two mutants in comparison to the intact K-RBP 
(Figure 6D). K-RBP1-98 was expressed at relatively higher level, 
while the BDK-RBP99-554 was expressed at lower level, suggest-
ing that the inability of K-RBP1-98 to cause repression was not 
due to inefficient expression of the K-RBP1-98 protein. Together 
our results suggest that the DNA-binding zinc finger domain of 
K-RBP plays an important role in repressing RTA-mediated trans-
activation of the ORF57 promoter.
Figure 4. K-RBP binds ORF57 promoter. (A) Schematic rep-
resentation of RRE in KSHV ORF57 promoter on which the 
locations of various putative promoter-regulatory elements 
are indicated. The whole 57RRE region was boxed. The GC-
rich region is in gray letters. The RBP-Jk binding element is 
underlined. The bold lines below the sequence indicate the 
ORF57 promoter probes that were used for EMSA. (B) EMSA 
of the clone #14, 57R, 57RRE2 and 57P probes with K-RBP 
protein. Purified His-tagged K-RBP was incubated with 32P 
labeled probes. Arrow indicates the weak binding between 
K-RBP and 57RRE2. (C) K-RBP binds 57R probe in EMSA. 
Experiment was performed as described in Figure 3C except 
that different unlabeled competitors were used as indicated. 
Arrow indicates the binding complex between K-RBP and 
57R. One μl K-RBP protein contains about 5 ng purified K-
RBP protein. 
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Inhibition of RTA binding to ORF57 promoter by K-RBP
The zinc finger domain of K-RBP is sufficient to repress RTA-
mediated ORF57 promoter transactivation and this domain medi-
ates DNA-binding activity, which suggests that K-RBP may inhibit 
RTA binding to ORF57 promoter to repress RTA-mediated transac-
tivation. We first showed that the zinc finger domain of K-RBP was 
sufficient to bind to ORF57 promoter. As shown in Figure 7A, the 
membrane-immobilized zinc finger domain of K-RBP was tightly 
bound to [α-32P] dATP labeled 57P probe as well as to the full-
length K-RBP. This is consistent with the result showing that the 
zinc finger domain was responsible for the DNA-binding activity of 
K-RBP (Figure 2C). Since RTA also binds to ORF57 promoter (Lukac 
et al., 2001), we then examined RTA binding to the promoter in the 
presence of K-RBP protein using EMSA. The baculovirus expressed 
RTA bound to 57P probe efficiently and the binding of RTA to 57P 
was competed efficiently by unlabeled 57P probe, but not by an Oct-
1 binding element (Figure 7B, lanes 3 and 4). In order to determine 
whether K-RBP affects RTA binding to 57P, EMSA was carried out 
in the presence of both RTA and K-RBP proteins. As shown in Fig-
ure 7B (lanes 6–8), RTA binding to 57P was decreased significantly 
as an increasing amount of K-RBP was added. The upper RTA/57P 
complex disappeared and the intensities of the middle and lower 
RTA/57P complexes decreased. Our results suggest that K-RBP can 
inhibit the binding of RTA to ORF57 promoter. The inhibition of 
RTA binding to ORF57 promoter by K-RBP likely contributes to the 
repression of RTA-mediated ORF57 promoter transactivation.
Figure 5. K-RBP suppresses KSHV ORF57 promoter is dependent on the GC-rich element. (A) Schematic representation of the luciferase promoter re-
porters used. (B–F) 293T cells were transfected with 100 ng of pGL3-basic as shown in (B), p57Pluc1 in (C), p57-3RRE in (D), p57-3RRE4 in (E), p57-
3RRE2 in (F) using the indicated amounts of K-RBP plasmid pcDNAK-RBP. The luciferase activities were detected at 24 h post-transfection. For all 
transfections, total DNA amounts used in each transfection were normalized by the addition of control plasmid. The percentages of inhibition by K-
RBP were indicated. The error bars indicate standard deviations of at least 3 independent experiments. Transfection efficiency for each experiment was 
normalized using a β-Gal expression plasmid as internal control. The basal levels of the promoter activity were normalized to 100%. 
Th e z i n c f i n g er dna-b in d i n g d oMai n o f K-rbP an d KshV rTa-Med i aTe d g en e e xP r es s i o n   227
Discussion
In this study, we characterized the DNA-binding activity of 
K-RBP and demonstrated that the DNA-binding zinc finger do-
main of K-RBP plays an important role in suppressing RTA-me-
diated ORF57 promoter transactivation. This study, as well as the 
earlier findings that KSHV RTA utilizes other cellular factors such 
as IRF-7 and RBP-Jκ to regulate the transactivation activity (Li-
ang et al., 2002; Wang et al., 2005), supports that the modulation of 
RTA–DNA binding is an important mechanism to regulate RTA 
activity.
DNA-binding activity of K-RBP
Even though KRAB-containing zinc finger proteins are pre-
dicted to function as sequence-specific transcriptional repressors 
by binding DNA via the zinc fingers and repressing transcrip-
tion using the KRAB domain (Gebelein and Urrutia, 2001; Urrutia, 
2003), recent studies have shown that zinc fingers are more diverse 
in selecting their binding partners than previously thought. The 
zinc fingers could be RNA or protein binding motifs (Brayer and 
Segal, 2008), and not all zinc finger proteins were shown to bind 
to DNA (Kwan et al., 2003). While some studies have suggested 
Figure 6. Effect of RTA-mediated transactivation of ORF57 promoter (p57Pluc1) by K-RBP and its mutants in BJAB cells. (A–C) BJAB cells were trans-
fected with 1 μg of p57Pluc1, expression plasmids of RTA and GAL4BD-tagged K-RBP in (A), K-RBP99-554 (zinc fingers) in (B), K-RBP1-98 (KRAB) 
in (C). The luciferase activities were detected at 48 h post-transfection. In all transfections, the total DNA amounts used in each transfection were nor-
malized by the addition of control expression plasmid. The basic promoter activity was normalized as 1 fold. The error bars indicate standard devia-
tions of at least 3 independent experiments. Transfection efficiency for each experiment was normalized using a β-Gal expression plasmid as internal 
control. (D) The expression of K-RBP and its mutants. The indicated proteins expressed from plasmids were immunoblotted with rabbit anti-GAL4BD 
antibody. The higher molecular band from the control plasmid in the first lane is probably a GAL4BD fusion protein translated from a read-through 
transcript from the vector. Tubulin was used as the loading control. (E) Schematic diagrams of K-RBP deletion mutants used and their effects on RTA-
mediated ORF57 transactivation. “+” and “−” indicate the ability of the various deletion clones to repress RTA-mediated transactivation. 
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that the − 1, + 3 and + 6 amino acids (Figure 1A) in the α-helical 
region of a zinc finger motif determine its DNA-binding specific-
ity (Pavletich and Pabo, 1991; Pavletich and Pabo, 1993; Wolfe et 
al., 2000), other studies have reported that other amino acids in 
the α-helix also contribute to the binding specificity of a zinc fin-
ger motif (Peng et al., 2002). In addition, in the context of a full-
length protein, not all zinc finger motifs bind DNA (Peng et al., 
2002; Zheng et al., 2000).
Since K-RBP binds DNA through its zinc fingers, in order to 
study whether K-RBP regulates RTA-mediated transactivation via 
DNA binding, we decided to examine the DNA-binding activity 
of K-RBP. We chose the random selection approach to identify K-
RBP binding DNA sequences because the accurate prediction of 
zinc finger protein binding sites is unreliable. Among the target 
sequences that were bound by K-RBP, the majority of them con-
tain GC-rich elements throughout the sequences. This is consistent 
with the findings that the consensus binding sequences of many 
zinc finger proteins are also GC-rich even though there are a few 
that are not (Christy and Nathans, 1989; Swirnoff and Milbrandt, 
1995). Our results suggest that K-RBP preferentially binds to the 
consensus sequence but its targets may not be limited to these se-
quences. The relatively broad binding specificity of K-RBP was 
also evidenced by its tight binding to ORF57 promoter, which does 
not show 100% similarity to the selected consensus sequence. The 
plasticity of K-RBP DNA binding is not unprecedented since this 
reflects the complexity of DNA binding for a protein with multi-
ple zinc fingers. This has also been observed in other zinc finger 
proteins. For example, the cellular protein Ying Yang 1 (YY1) can 
bind to several different consensus sequences (Hyde-DeRuyscher 
et al., 1995; Kim and Kim, 2008). Further studies such as muta-
genesis analysis will be needed to dissect the preferential binding 
sites and the fingers within K-RBP responsible for DNA and pro-
tein bindings.
The repression of KSHV ORF57 promoter activity by K-RBP
KSHV establishes latency after primary infection, which is char-
acterized by the repression of a number of viral lytic genes. There 
are multiple mechanisms involved in suppression of KSHV lytic 
gene expression but they are not fully understood. A number of 
cellular factors may contribute to the maintenance of KSHV la-
tency, and K-RBP is one of them (Brown et al., 2003; Gwack et al., 
2001, 2003; Wang et al., 2005). K-RBP negatively regulates RTA-ac-
tivation of lytic genes such as ORF57 gene (Yang and Wood, 2007). 
Our results here indicate that one of the mechanisms for repres-
sion of ORF57 expression is the direct binding of K-RBP to its pro-
moter. The binding of K-RBP to viral ORF57 promoter may bring 
co-repressors to silence gene expression. An example is TIF1β, 
which was found to interact with the KRAB domain of K-RBP and 
some other KRAB-containing proteins (Abrink et al., 2001; Yang 
and Wood, 2007). The repression mechanism of KRAB-containing 
zinc finger proteins has been shown to involve recruitment of re-
pression complex by KRAB domain, including TIF1β (transcrip-
tion intermediary factor 1β) (Friedman et al., 1996; Kim et al., 1996; 
Moosmann et al., 1996). The KRAB/TIF1β complex recruits cellu-
lar factors heterochromatin protein 1 (HP1) family, a family of non-
histone heterochromatin-associated proteins with gene-silencing 
function, HDAC and SETDB1, a SET domain-containing protein 
that methylates lysine 9 of histone H3 to the DNA regulatory re-
gion (Cammas et al., 2004; Lechner et al., 2000; Nielsen et al., 1999; 
Peng et al., 2000; Ryan et al., 1999; Schultz et al., 2001, 2002; Sripa-
thy et al., 2006). This may also explain why the KRAB domain of 
K-RBP in the absence of the zinc finger motifs can moderately en-
hance RTA-mediated transactivation (Figure 6C). It may function 
as a dominant-negative mutant that interacts with repressors to 
prevent their targeting to ORF57 promoter to mediate repression.
Our study showed that the zinc finger domain of K-RBP alone 
can bind to ORF57 promoter, compete with RTA in binding to 
ORF57 promoter and repress RTA-activated ORF57 promoter. 
This suggests that the DNA-binding activity of K-RBP plays an 
important role for inhibiting RTA-mediated transactivation. How-
ever, the DNA-binding activity of K-RBP may be not the sole 
mechanism in repressing RTA-mediated transactivation. An ex-
ample is the KSHV ORFK8, it contains the GGGGGTGG sequence 
motif and its activation by RTA can be repressed by K-RBP (Yang 
and Wood, 2007). However, K-RBP cannot repress ORFK8 pro-
Figure 7. Inhibition of RTA binding to ORF57 promoter by K-RBP. (A) 
The zinc finger domain of K-RBP binds ORF57 promoter. The E. coli ex-
pressed His-tagged zinc finger domain, full-length K-RBP and E. coli ly-
sate were resolved on SDS-PAGE, transferred to PVDF membrane and 
analyzed by Coomassie blue staining (left panel). The second membrane 
with the same samples was refolded and hybridized to the 57P probe la-
beled with [α-32P] dATP (right panel). (B) Baculovirus expressed RTA, E. 
coli expressed K-RBP and [α-32P] dATP labeled 57P probe were used in 
EMSA. The EMSA was performed as described in Figure 3C except that 
different unlabeled competitors and proteins were used as indicated in 
the figure. Open arrows indicate specific binding of RTA to probes. Filled 
arrows indicate the binding of K-RBP to probes. Numbers below the 
bands indicate the relative intensities of the bands measured by Image J. 
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moter expression in the absence of RTA (unpublished data). This 
suggests that the interaction between K-RBP and RTA may also 
play a role in the repression of RTA-mediated transactivation, in 
addition to the DNA-binding activity of K-RBP. It is also possible 
that a combination of the above mechanisms could be involved in 
the repression of RTA-mediated transactivation by K-RBP.
The potential role of K-RBP in KSHV life cycle
We have recently found that RTA could induce K-RBP degra-
dation through a proteasome-dependent pathway leading to lytic 
reactivation (Yang et al., 2008). It is likely that there is a dynamic 
relationship between repression by K-RBP and K-RBP degrada-
tion induced by RTA in KSHV infected cells, and this balance may 
change at various stages of KSHV infection. During latency, RTA-
mediated transactivation may be blocked by K-RBP and other re-
pressors when RTA expression level is very low. However, during 
lytic induction, when RTA expression is induced, RTA may over-
come the suppression and lead to lytic replication.
The identification of K-RBP as a repressor of KSHV gene ex-
pression and as an ORF57 promoter binding protein is interest-
ing because other KRAB-containing zinc finger proteins have also 
been found to be involved in regulating viral replication. K-RBP 
is one of a few members of the zinc finger protein family that are 
known to repress viral replication. The KRAB-containing zinc fin-
ger protein OTK18 represses human immunodeficiency virus type 
1 (HIV-1) replication (Carlson et al., 2004). Recently, a KRAB-con-
taining protein was found to repress lentivirus proviral transcrip-
tion (Bulliard et al., 2006). Engineered KRAB-containing zinc fin-
ger proteins were also used to repress HIV transcription and 
replication in several studies (Eberhardy et al., 2006; Reynolds et 
al., 2003; Segal et al., 2004). The DNA-binding activity plays an 
important role in specifying its effective targets. It is possible that 
the KRAB-containing zinc finger proteins play a broader role and 
function as intracellular antiviral molecules to inhibit viral replica-
tion. This possibility needs to be further explored.
K-RBP may have other roles in KSHV life cycle in addition to 
transcriptional regulation. The origin of replication of KSHV is a 
GC-rich region, whether K-RBP binds this region to regulate viral 
replication needs to be investigated (Russo et al., 1996). K-RBP may 
also regulate the expression of other KSHV genes or other viruses 
such as Epstein–Barr virus (EBV), since co-infection of primary ef-
fusion lymphoma by both KSHV and EBV occurs frequently (Drex-
ler et al., 1998), and there are a number of KSHV and EBV viral pro-
moters harboring GC-rich elements. Further study will be needed to 
map other K-RBP binding promoters on KSHV viral genome. This 
may include investigating the in vivo binding targets of K-RBP on 
viral and cellular genome by Chromatin immunoprecipitation fol-
lowed by new deep pyrosequencing technique. In conclusion, the 
regulation of KSHV gene expression by K-RBP through its DNA-
binding activity suggests a DNA binding-dependent mechanism 
for K-RBP to regulate KSHV gene expression.
Materials and Methods
Plasmids
Expression plasmids pcDNAK-RBP and pcDNAORF50, which 
encode full-length K-RBP and KSHV RTA, have been described 
elsewhere (Wang et al., 2001). The mammalian expression plas-
mids GAL4 DNA-binding domain (GAL4BD)-tagged K-RBP and 
its mutant clones pBDK-RBP, pBDK-RBP42-98, pBDK-RBP1-98, 
pBDK-RBP214-554 and pBDK-RBP99-554 encoding full-length, K-
RBP fragments from amino acids 42 to 98, 1 to 98, 214 to 554 and 
99 to 554 respectively, have also been described elsewhere (Yang 
and Wood, 2007). The E. coli expression plasmids pET28K-RBP, 
pET28K-RBP1-98 and pET28K-RBP141-554 were constructed by 
PCR amplification of corresponding K-RBP DNA fragments and 
inserting into pET28 vector. Reporter plasmid p57Pluc1, contain-
ing promoter region of KSHV ORF57, has also been described pre-
viously (Duan et al., 2001). The luciferase reporter plasmids p57-
3RRE, p57-3RRE2 and p57-3RRE4, as shown in Figure 5, were 
constructed by amplifying corresponding DNA fragments of 
ORF57 promoter by PCR and inserting into pGL3-basic vector 
(Promega, Madison, WI). The β-galactosidase (β-Gal) expression 
plasmid pCMV-β was purchased from BD Clontech (Mountain 
View, CA) and used for the normalization of transfection effi-
ciency. All inserts amplified by PCR were confirmed by DNA se-
quence analysis.
Expression, purification and refolding of recombinant K-RBP protein
E. coli DE3 cells containing His-tagged K-RBP expression plas-
mid pET28K-RBP were induced by 1 mM isopropyl-beta-d-thio-
galactopyranoside (IPTG) at 37 °C for 4–5 h to express K-RBP 
protein. The cells were suspended in 1× PBS containing 1 mM 
Phenylmethylsulphonylfluoride (PMSF) and then lysed by soni-
cation. The insoluble fraction was collected by centrifugation and 
washed sequentially with 1× PBS containing 2 M urea, 0.1% SDS, 
1% NP-40 and 1% TritonX-100. The majority of the insoluble frac-
tion after extensive washing contains K-RBP protein (see Figure 
1B). The purified protein was solubilized in 1× PBS containing 8 M 
Urea, and was renatured by successive dialysis against refolding 
buffer (25 mM HEPES, pH 7.9, 50 mM NaCl, 0.1% NP-40, 1 mM 
PMSF, 0.16 mM dithiothreitol [DTT], 10 μM ZnSO4, 10% glycerol) 
containing 4, 2, 1 and 0 M Urea at 4 °C. The resulting protein was 
evaluated by coomassie blue staining and Western blot analysis 
with anti-His antibody following SDS-PAGE. The protein expres-
sion of K-RBP1-98 and K-RBP141-554 was carried out in E. coli 
similar to K-RBP protein.
Expression and purification of recombinant KSHV RTA protein
KSHV RTA was expressed in Sf9 cells using Bac-N-Blue bacu-
lovirus expression system (Invitrogen, Carlsbad, CA). Briefly, full-
length KSHV RTA was PCR-amplified and cloned into pBlueBa-
cHis2A vector, which was co-transfected into Sf9 cells with the 
wild-type baculovirus vector. Recombinant virus was plaque pu-
rified twice to obtain a high titer stock. To express protein, Sf9 
cells were infected at an MOI of 10 with the recombinant virus. 
The purification of His-tagged RTA protein was carried out using 
Ni-NTA superflow (Qiagen, Valencia, CA) according to the manu-
facturer’s recommendation.
DNA cellulose binding assay
DNA cellulose binding assay was carried out according to pub-
lished procedure with modifications (Nishiya et al., 1998). Briefly, 
approximately 5 μg of K-RBP protein was incubated with 5 mg of 
cellulose or double-stranded (ds) DNA cellulose in binding buf-
fer (25 mM HEPES, pH 7.9, 50 mM KCl, 0.1% NP-40, 1 mM PMSF, 
0.16 mM DTT, 10 μM ZnSO4, 10% glycerol) in 0.5 ml volume over-
night at 4 °C. The cellulose was preincubated with 5% bovine se-
rum albumin (BSA) in binding buffer for 1 h prior to use. After in-
cubation with K-RBP, the cellulose/protein complex was washed 
4 times with binding buffer. The protein bound to DNA cellulose 
was eluted with 1.25% SDS or binding buffer containing increas-
ing concentration of NaCl, resolved by SDS-PAGE, and then de-
tected by Western blot analysis using rabbit anti-K-RBP antibody.
DNA filter binding assay
Filter binding assay was adapted from published procedure 
with some modifications (Jheon et al., 2001). Cell lysates from 
E. coli were separated by SDS-PAGE and transferred to Polyvi-
nylidene fluoride (PVDF) membrane. The membrane was rena-
tured overnight at 4 °C in binding buffer (25 mM HEPES, pH 
7.9, 50 mM KCl, 0.1% NP-40, 1 mM PMSF, 0.16 mM DTT, 10 μM 
ZnSO4, 10% glycerol, 30–50 μg/ml salmon testes DNA). DNA 
probes were end-labeled with [α-32P] dATP (PerkinElmer Life 
Sciences, Waltham, MA) using Klenow DNA polymerase (New 
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England Biolabs, Ipswich, MA). Approximately 1 × 105 cpm/ml 
of the labeled DNA was hybridized to the membrane in bind-
ing buffer overnight at room temperature. The membrane was 
washed for 6 h (3–4 times) at room temperature in 50 mM KCl, 
and the protein/DNA-binding complexes were analyzed by 
autoradiography.
Selection of K-RBP binding sequences
The selection of consensus DNA-binding sequences of K-
RBP was carried out by the Selected and Amplified Binding Se-
quence (SAAB) method with modifications (Blackwell and Wein-
traub, 1990). For the first set of binding sequence selection, a 
pool of double-stranded random oligomers was obtained by 
PCR amplification using the 63-base random oligonucleotide 
N27 (5′-ATGGTACCGAAGTCCTCA-N27-GACATCAGTCTC-
GAGTCT-3′) as template (125 ng), 0.5 μg of primer 1 (5′-ATGG-
TACCGAAGTCCTCA-3′) and 0.5 μg of primer 2 (5′-AGACTC-
GAGACTGATGTC-3′). The dsDNA (~ 0.5 μg) was incubated with 
0.5 μg of His-tagged K-RBP protein for 1 h with rotation in a final 
volume of 150 μl of binding buffer (25 mM HEPES, pH 7.9, 50 mM 
KCl, 0.1% NP-40, 1 mM PMSF, 0.16 mM DTT, 10 μM ZnSO4, 10% 
glycerol) containing 10 μg/ml poly(dI·dC) at room temperature. 
The resulting K-RBP/DNA complex was isolated by incubating 
the solution with Ni-NTA superflow for 1 h, and the beads were 
washed 4 times by binding buffer. The K-RBP/DNA complex was 
separated from Ni-NTA by 100 μl of elution buffer (250 mM imid-
azole, 300 mM NaCl, 50 mM NaH2PO4), heated at 95 °C for 10 min 
and partially purified by Qiagen nucleotide removal kit. Ten μl of 
the recovered DNA was amplified by PCR with primers 1 and 2. 
After seven rounds of selection and purification, the final round 
PCR product was cloned directly into pGEM-T easy vector system 
(Promega), amplified and sequenced.
The second set of binding sequence selection was performed us-
ing a pool of double-stranded random oligomers obtained by PCR, 
using 100 ng of the 68-base random oligonucleotide N14-CGG-N15 
(5′-GACTGACAGATCTGTGAG-N14-CGG-N15-CTGTCATATGA-
CAGTCAC-3′) as template, 0.5 μg of primer 3 (5′-GACTGACA-
GATCTGTGAG-3′) and 0.5 μg of primer 4 (5′-GTGACTGTCATAT-
GACAG-3′). Binding was carried out as described above but the 
selection was carried out for eight rounds. The PCR product from 
the eighth round was inserted into pGEM-T and sequenced.
DNA sequencing and analysis
After multiple rounds of selection, PCR amplification and pu-
rification, the affinity-selected oligonucleotides were ligated into 
the pGEM-T vector. After transforming into E. coli, the DNA in-
serts from the resulting clones were sequenced. The sequences 
were analyzed, aligned using the BioEdit sequence analysis pro-
gram and adjusted manually.
Electrophoretic mobility shift assay (EMSA)
The double-stranded oligonucleotides used for EMSA were 
end-labeled with [α-32P] dATP using Klenow DNA polymerase. 
The labeled probes were incubated with the protein for 30 min in 
binding buffer (10 mM Tris-HCl [pH 7.5], 150 mM KCl, 5.7 mM 
MgCl2, 1 mM EDTA, 0.2 μg of poly[dI·dC], 5 μg of BSA, 0.67 mM 
DTT, 0.67 mM PMSF, 5% glycerol) in the presence or absence of 
unlabeled probes. If antibody was added to detect supershift, 
the antibody and protein were preincubated for 20 min before 
the labeled probes were added. The protein/DNA-binding sam-
ples were loaded onto a 4.5% polyacrylamide gel in 1xTGE buf-
fer (5 mM Tris, 190 mM glycine, and 1 mM EDTA [pH 8.3), then 
dried and exposed to X-ray film. Signal intensities were quan-
tified by the NIH Image J software. The probes 57P, 57R and 
57RRE2 that were used are indicated in Figure 4A. The probe 
clone #14 is indicated in Figure 3D. One strand of Oct-1 binding 
sequence is: 5′-TGTCGAATGCAAATCACTAG-3′.
Antibodies
Anti-K-RBP antibody was described elsewhere (Yang and 
Wood, 2007). The mouse anti-tubulin monoclonal antibody was 
purchased from Sigma (St. Louis, MO). The mouse anti-Flag M2 
monoclonal antibody was purchased from Stratagene (La Jolla, 
CA) and the mouse anti-His monoclonal antibody was purchased 
from BD Clontech. Mouse and rabbit anti-GAL4BD antibodies 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell culture, transfection, and luciferase assay
Human 293T cells were grown in Dulbecco’s Modified Eagle 
Medium (DMEM, Invitrogen) supplemented with 10% fetal bo-
vine serum (FBS, Invitrogen) and 1% penicillin-streptomycin (Me-
diatech, Manassas, VA) at 37 °C with 5% CO2. Transfection of 
293T cells was carried out using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s recommendations. Human BJAB cells 
were grown in RPMI 1640 medium (Gibco BRL) supplemented 
with 10% FBS and 1% penicillin-streptomycin at 37 °C with 5% 
CO2. Transfection of BJAB cells was conducted using Amaxa Nu-
cleofactor according to manufacturer’s recommendations. For all 
transfections, the total DNA amounts used in each transfection 
were normalized by adding control plasmid. Luciferase activ-
ities were determined at 48 h post-transfection by the Luciferase 
Assay System (Promega) according to the manufacturer’s recom-
mendations. Each result was an average of at least three indepen-
dent transfections. Transfection efficiency for each experiment 
was normalized by co-transfecting with a β-gal expression plas-
mid pCMV-β which was used as internal control.
Western blotting analysis
Proteins were separated by SDS-PAGE and transferred to 
PVDF membrane. The membrane was blocked with 3–5% non-
fat dry milk in TBST (50 mM Tris [pH 7.5], 200 mM NaCl, 0.05% 
Tween 20) at room temperature for 1 h. The membrane was then 
incubated with primary antibody with the same concentration 
of milk in TBST for 1 h at room temperature, washed three times 
with TBST for 15 min, then incubated with the HRP-conjugated 
secondary antibody at room temperature for 1 h. The membrane 
was again washed three times with TBST, treated with SuperSig-
nal (Pierce Biotechnology) detection reagents and exposed to Ko-
dak Light film.
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